News
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
July 14
Salt Lake City – July 14, 2021 – Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
May 19– The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time
SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
May 18– Data presented at the ISPOR 2021 Conference illustrating clinical benefit as well as cost savings
Salt Lake City – May 18, 2021 – Sera Prognostics Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to...
-
April 28– Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test –
SALT LAKE CITY, April 28, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative...
-
April 13– Highly accomplished attorney joins Sera to develop its legal and intellectual property functions –
SALT LAKE CITY, April 13, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company®, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
Sign up for our investor relations email list here.